ANTIPHOSPHOLIPID SYNDROME (APS)
Clinical trials for ANTIPHOSPHOLIPID SYNDROME (APS) explained in plain language.
Never miss a new study
Get alerted when new ANTIPHOSPHOLIPID SYNDROME (APS) trials appear
Sign up with your email to follow new studies for ANTIPHOSPHOLIPID SYNDROME (APS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested to tame dangerous antibodies in blood clot disorder
Disease control CompletedThis study tested if adding a drug called Telitacicept to standard treatment could help control harmful antibody levels in adults with a high-risk type of Antiphospholipid Syndrome (APS), a condition that causes abnormal blood clotting. Twenty patients were randomly assigned to r…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME (APS)
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Old malaria drug tested to protect blood vessels in rare autoimmune disease
Disease control CompletedThis study tested whether adding hydroxychloroquine to standard treatment could improve blood vessel function in people with antiphospholipid syndrome (APS), a condition that causes dangerous blood clots. In this small, completed Phase 2 trial, 25 participants were randomly assig…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME (APS)
Phase: PHASE2 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC